Online perioperative education to support head and neck cancer patients and their caregivers

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

CareOrbit is a digital perioperative education and care-navigation platform designed to guide adults with head and neck cancer through their surgical journey with structured modules, videos, and centralized resources. The study compares CareOrbit against standard perioperative education to determine its effect on patient understanding, satisfaction, and key clinical outcomes. Eligible participants are adults with a new head and neck cancer diagnosis planning or scheduled for free flap surgery or total laryngectomy, or serving as a caregiver, who have internet access and English proficiency. The trial is conducted at Washington University School of Medicine with collaboration from The Foundation for Barnes-Jospital, focusing on whether digital education can fill gaps in perioperative support. Primary endpoints include patient-reported understanding and satisfaction, along with selected clinical outcomes related to perioperative care.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years of age or older
* Have a new diagnosis of head and neck cancer
* Planning or scheduled to undergo free flap surgery and/or total laryngectomy, or caregiver to eligible patients
* Have internet access
* English speaking

Exclusion Criteria:

* Younger than 18 years of age
* No internet access
* Non-English speaking

Where it's running

• Washington University School of Medicine
  St Louis, Missouri, United States Recruiting

Study contacts

• Principal investigator: Jason Rich, MD, FACS — Washington University School of Medicine
• Study coordinator: Jason Rich, MD, FACS
• Email: richj@wustl.edu
• Phone: 314-747-3742

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Lidocaine Infiltration to See If It Helps Inflammation and Brain Function After Head and Neck Cancer Surgery

  This study tests whether different amounts of lidocaine injected into the surgical area can influence inflammation and brain-related outcomes after major head and neck cancer surgery in adults.

  Recruiting Phase 4 University Medical Centre Ljubljana · Ljubljana · NCT07922759

• Swallowing Rehab Program for Head and Neck Cancer Patients on Chemoradiation

  A structured swallowing rehabilitation program is tested to see if it improves swallowing, jaw mobility, and pain for head and neck cancer patients undergoing chemoradiation.

  Recruiting Delta University for Science and Technology · Cairo · NCT07795294

• Tests whether far infrared therapy and nerve stimulation help with side effects in head and neck cancer patients receiving chemoradiotherapy

  This trial tests if adding far infrared therapy and transcutaneous electrical nerve stimulation to standard care can reduce treatment-related side effects for adults with head and neck cancer undergoing chemoradiotherapy.

  Recruiting Buddhist Tzu Chi General Hospital · Hualien City, Hualien County · NCT07689019

• Oral, Fecal and Tumor Microbiome Atlas in Colombian Patients With Advanced Solid Tumors Receiving First-Line Immunotherapy

  This study tests how the oral, gut, and tumor microbiomes relate to response to first-line immunotherapy in Colombian adults with advanced solid cancers.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07676461

• ICG Fluorescence Imaging to Guide Head and Neck Free Flap Surgery

  This trial tests whether using intraoperative indocyanine green (ICG) fluorescence imaging helps surgeons improve flap outcomes compared with standard assessments in adults undergoing head and neck free flap reconstruction.

  Recruiting Phase 4 Region Skane · Malmö · NCT07635420

• Assessing safety and efficacy of new treatments for advanced solid tumors

  This study is testing two new treatments for patients with advanced solid tumors to see if they are safe and effective.

  Recruiting at 10 sites Phase 1/2 Lumara Bio Oncologics GmbH · Melbourne and 9 other locations · NCT05706129

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.